With over 25 years of experience in the field of microbial systems, Wacker Biotech GmbH is a preferred partner for the contract manufacturing of therapeutic proteins (biologics). Our focus is on the development of stable, high-efficiency processes, and GMP-compliant production in our certified multifunctional facility. Our customers include both mid-sized and globally-active pharmaceutical and biotech companies.
Wacker Biotech’s experience with therapeutic proteins dates back to the 1980s, when the key focus was on developing interferon alpha. Biopharmaceuticals have been commercially developed and produced since 1999. Back then, ProThera GmbH was established as a spin-off of the state-owned Hans Knöll Institute in Jena. Wacker Biotech GmbH is a wholly-owned WACKER Group subsidiary, operating since January 2005 as the direct successor of ProThera GmbH. In 2014, acquisition of Scil Proteins Production GmbH in Halle expanded the production capacity by a 1,500-liter line and added refolding expertise to the portfolio.
The highly competent CMO team of some 160 experienced employees in Jena and Halle offers its customers excellent and extensive services.